TXN and COVID-19: Considering the above, the reduction in GSH levels, which inhibits the production of the most ROS-activated pro-inflammatory cytokines, supports the pro-inflammatory effects of Trx and promotes the increase in TNFα levels seen in COVID-19 patients.